Targeted sequencing of 46 Bangladeshi colorectal cancer samples found KRAS mutations in 10.87% of cases (including G12D, G12V, and G13D variants) and no BRAF V600E mutations, a notably lower prevalence than typically reported in other populations. (Asian Pacific Journal of Cancer Prevention)
KRAS and BRAF Hotspot Mutations Show Lower Prevalence in Bangladeshi CRC Patients
The CRC Digest